Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.
Department of Genetics, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Front Immunol. 2021 Feb 26;12:606620. doi: 10.3389/fimmu.2021.606620. eCollection 2021.
Polycystic ovary syndrome (PCOS) and Hashimoto's thyroiditis (HT) are endocrine disorders that commonly occur among young women. A higher prevalence of HT in women with PCOS, relative to healthy individuals, is observed consistently. Combined occurrence of both diseases is associated with a higher risk of severe metabolic and reproductive complications. Genetic factors strongly impact the pathogenesis of both PCOS and HT and several susceptibility loci associated with a higher risk of both disorders have been identified. Furthermore, some candidate gene polymorphisms are thought to be functionally relevant; however, few genetic variants are proposed to be causally associated with the incidence of both disorders together.
多囊卵巢综合征(PCOS)和桥本甲状腺炎(HT)是常见于年轻女性的内分泌疾病。多囊卵巢综合征患者中桥本甲状腺炎的患病率相对健康个体更高,这一现象一直存在。两种疾病同时发生与更严重的代谢和生殖并发症风险增加相关。遗传因素对 PCOS 和 HT 的发病机制有重要影响,已经确定了几个与两种疾病风险增加相关的易感基因座。此外,一些候选基因多态性被认为具有功能相关性;然而,很少有遗传变异被认为与这两种疾病的同时发生有因果关系。